Evidence map›Paper›PMID 26021319›Full record

ArticleBMC medicine2015

High prevalence of hypertension and of risk factors for non-communicable diseases (NCDs): a population based cross-sectional survey of NCDS and HIV infection in Northwestern Tanzania and Southern Uganda.

Bazil Kavishe, Samuel Biraro, Kathy Baisley, Fiona Vanobberghen, Saidi Kapiga, Paula Munderi, Liam Smeeth, Robert Peck, Janneth Mghamba, Gerald Mutungi and 7 more

Open access · goldAbstract read
In one paragraph

Article in BMC medicine, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 132 papers, 7 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
132citing papers in PubMed, 7 pooled it
29.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

132 citing papers in PubMed, 7 syntheses or guidelines pooled it, 210 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Trial
  9. Trial
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article

72 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 7 institutions in 3 countries.

Bazil KavisheMwanza Intervention Trials Unit, National Institute for Medical Research, PO 11936, Mwanza, Tanzania. bazil.baltazar@mitu.or.tz.
Samuel BiraroMRC/UVRI Uganda Research Unit on AIDS / Uganda Virus Research Institute, Entebbe, Uganda. samuel.biraro@mrcuganda.org.
Kathy BaisleyMRC Tropical Epidemiology Group, London School of Hygiene & Tropical Medicine, Keppel Street, London, WC1E 7HT, UK. kathy.baisley@lshtm.ac.uk.
Fiona VanobberghenMwanza Intervention Trials Unit, National Institute for Medical Research, PO 11936, Mwanza, Tanzania. fiona.vanobberghen@lshtm.ac.uk.
Saidi KapigaMwanza Intervention Trials Unit, National Institute for Medical Research, PO 11936, Mwanza, Tanzania. saidi.kapiga@lshtm.ac.uk.
Paula MunderiMRC/UVRI Uganda Research Unit on AIDS / Uganda Virus Research Institute, Entebbe, Uganda. paula.munderi@mrcuganda.org.
Liam SmeethMRC Tropical Epidemiology Group, London School of Hygiene & Tropical Medicine, Keppel Street, London, WC1E 7HT, UK. liam.smeeth@lshtm.ac.uk.
Robert PeckWeill Bugando School of Medicine, Mwanza, Tanzania. rnp2002@gmail.com.
Janneth MghambaMinistry of Health and Social Welfare, Dar es Salaam, Tanzania. janneth.mghamba@yahoo.com.
Gerald MutungiMinistry of Health, Kampala, Uganda. gnmutungi@yahoo.com.
Eric IkoonaMinistry of Health, Kampala, Uganda. ikoonae@yahoo.com.
Jonathan LevinMRC/UVRI Uganda Research Unit on AIDS / Uganda Virus Research Institute, Entebbe, Uganda. jonathan.levin@mrcuganda.org.
Maria Assumpció Bou MonclúsMwanza Intervention Trials Unit, National Institute for Medical Research, PO 11936, Mwanza, Tanzania. abm696@hotmail.com.
David KatendeMRC/UVRI Uganda Research Unit on AIDS / Uganda Virus Research Institute, Entebbe, Uganda. david.katende@mrcuganda.org.
Edmund KisangaMwanza Intervention Trials Unit, National Institute for Medical Research, PO 11936, Mwanza, Tanzania. edmund.kisanga@mitu.or.tz.
Richard HayesMRC Tropical Epidemiology Group, London School of Hygiene & Tropical Medicine, Keppel Street, London, WC1E 7HT, UK. richard.hayes@lshtm.ac.uk.
Heiner GrosskurthMRC Tropical Epidemiology Group, London School of Hygiene & Tropical Medicine, Keppel Street, London, WC1E 7HT, UK. heiner.grosskurth@lshtm.ac.uk.
London School of Hygiene & Tropical Medicine · GBNational Institute for Medical Research · TZUganda Virus Research Institute · UGMinistry of Health · UGBugando Medical Centre · TZMinistry of Health and Social Welfare · TZMwanza Intervention Trials Unit · TZ

Funding

Medical Research Council 99430Medical Research Council G0700837Medical Research Council G0901756Medical Research Council G1002650Medical Research Council MC_UP_A910_1112Medical Research Council MR/K006584/1Wellcome Trust 098504
6 · The paper itself

Abstract

backgroundThe burden of non-communicable diseases (NCDs) is increasing in sub-Saharan Africa, but data available for intervention planning are inadequate. We determined the prevalence of selected NCDs and HIV infection, and NCD risk factors in northwestern Tanzania and southern Uganda.

methodsA population-based cross-sectional survey was conducted, enrolling households using multistage sampling with five strata per country (one municipality, two towns, two rural areas). Consenting adults (≥18 years) were interviewed using the WHO STEPS survey instrument, examined, and tested for HIV and diabetes mellitus (DM). Adjusting for survey design, we estimated population prevalences of hypertension, DM, obstructive pulmonary disease, cardiac failure, epilepsy and HIV, and investigated factors associated with hypertension using logistic regression.

resultsAcross strata, hypertension prevalence ranged from 16 % (95 % confidence interval (CI): 12 % to 22 %) to 17 % (CI: 14 % to 22 %) in Tanzania, and from 19 % (CI: 14 % to 26 %) to 26 % (CI: 23 % to 30 %) in Uganda. It was high in both urban and rural areas, affecting many young participants. The prevalence of DM (1 % to 4 %) and other NCDs was generally low. HIV prevalence ranged from 6 % to 10 % in Tanzania, and 6 % to 12 % in Uganda. Current smoking was reported by 12 % to 23 % of men in different strata, and 1 % to 3 % of women. Problem drinking (defined by Alcohol Use Disorder Identification Test criteria) affected 6 % to 15 % men and 1 % to 6 % women. Up to 46 % of participants were overweight, affecting women more than men and urban more than rural areas. Most patients with hypertension and other NCDs were unaware of their condition, and hypertension in treated patients was mostly uncontrolled. Hypertension was associated with older age, male sex, being divorced/widowed, lower education, higher BMI and, inversely, with smoking.

conclusionsThe high prevalence of NCD risk factors and unrecognized and untreated hypertension represent major problems. The low prevalence of DM and other preventable NCDs provides an opportunity for prevention. HIV prevalence was in line with national data. In Tanzania, Uganda and probably elsewhere in Africa, major efforts are needed to strengthen health services for the PREVENTION, early detection and treatment of chronic diseases.

Indexed as

AdolescentAdultAgedAlcoholismChronic DiseaseCommunicable DiseasesCross-Sectional StudiesDiabetes MellitusFemaleHealth Services Needs and DemandHIV InfectionsHumansHypertensionLogistic ModelsMaleMiddle Aged

Identifiers

PMID26021319
PMCPMC4476208
OpenAlexW1914924713

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.